Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
If Denner/Sarissa were to sell their APRI position how fast would we hear about it throught sec filing, anyone know how many days later?
PuuliTuku
Any estimate of short amount after yesterdays trading?
PuuliTuku
Exactly, even 6$/share puts apri around at just 90million mcap.
PuuliTuku
Yeah theyre trapped haha.
Their only hope is casinokid is right and rejection is coming.
PuuliTuku
Hello Lostcoastkid, that's a longass time! Dare I ask your average price in this?
PuuliTuku
Yes, the next week is finally it.
PuuliTuku
Old song but surely Denner sees some potential in the company?
Otherwise he would had sold his position after the failed fispemifene trials?
PuuliTuku
Imagine if Denner would take more active role in APRI affairs after the approval..
PuuliTuku
I think Denner bought around 1$ (pre-split) and his warrants were around 0.8$(?)..
PuuliTuku
God bless the president.
PuuliTuku
I read article about it, gave the impression they were more after proellex.
PuuliTuku
ARMISTICE CAPITAL LLC now owns 9.6% of APRI shares according to their filed 13G form.
Any thoughts about that?
Wonder what the total instutional shares% is nowadays, Armstice Denner Sarissa Forendo(?) etc combined?
PuuliTuku
Could be but there's cheaper toilet paper.
PuuliTuku
Sec filing today, looks like A.Denner bought 6104 shares more.
Anyone wiser than me wanna try to guess why such a tiny amount?
Buying loads or selling lots I could understand.
PuuliTuku
My shareprice guesstimate after filing was in 2.5$'sh range, lets see if we can get up there in nearby future.
PuuliTuku
Looks like I was right for once.
PuuliTuku
I see, thanks for correction.
PuuliTuku
One more thing: "As of March 2015, the drugs sector has an average P/E ratio of 24".
PuuliTuku
Yes I am serious.
Good discussion oldtimer.
20 million shares then.
I go with option A because Allergan wants its ED drug, dont you think FDA is gonna come down on ED-product health problems sooner or later?
And 10% marketshare sounds realistic to me so 35m royalties/year.
Why do you say their spendings/quarter will explode after vitaros approval? Minimal personnel, vitaros not taking resources anymore, they have stated they will not go forward with any other drugs without bigger partner.
If vitaros gets approved, ddaip hcl gets approved for human use, Im sure you are familiar with its ability to enchance drugs effect by making it more effective passing thru the skin. If I was on my home computer I could link some articles. Thats why I think outlicensing to right company could bring extra revenues.
PuuliTuku
But to answer in aprilov's absense, I'll throw these numbers outta my head: we're standing at 1.35$ now, around 2.5$ after filing, 7-10$ after approval, 15-25$ if imminent buyout, if sales start growing strong then obviously higher later.
What do ya think?
PuuliTuku
Dont forget DDAIP HCL outlicensing to combine with other drugs, RayVa, fispemiphene US rights(LUTS effective still right?), that woman arousal drug whatsitsname.
Got to take those in consideration too right?
PuuliTuku
You heard it here first: NDA filing before end of august.
PuuliTuku
Apri holders get one benefit from Mexico if sales get going: vitaros brand grows bigger.
PuuliTuku
Almost 3 million volume today, any guesses wtf was that about?!?
PuuliTuku
So there was no stiffening of penises and beyond mild side effects were observed?
Dont suppose you have proof for this, casinokid?..
PuuliTuku
On the other hand, this news is over 6 years old:
http://www.nbcnews.com/id/42573534/ns/business-press_releases/#.WUqx7OuGOUk
Possible effect on APRI?
FDA has created special "Orphan Designation SWAT Team" to clear 200 orphan designation request backlog within 90 days, @SGottliebFDA says
— Meg Tirrell (@megtirrell) June 20, 2017
Claytrader posted so we're definetly going under a dollar today.
PuuliTuku
Shareholder meeting today, I have a feeling there could be surprises stored
PuuliTuku
Havent voted.
PuuliTuku
Were unused votes considered NO or was that just about warrants?
PuuliTuku
No surprises in the ER, no even caller questions in the CC, cash should be good till Q3/2018 and focus in now all on the NDA and earlish 2018 approval.
So nothing now but waiting left
PuuliTuku
After november FDA meeting it was stated that no new studies was required for the NDA yet shortly after they started one. Was the denial to calm down the shareholders as company was very low on cash? Atleast we now have a pretty good guess why they needed extra funding.
"Good" news are that the study should end next month and then starts the Q3/2017 when the NDA filing is due.
PuuliTuku
What's with the volume, are these shares from the offering or real trading?
PuuliTuku
Price manipulation before an offering or some real good news incoming soon?
PuuliTuku
If they are planning an offering, can there be any other reason than they are still some equity short?
PuuliTuku
Hi.
Can you tell more about this "Then they found out at the November meeting that their methodology was trash and that they needed to rewrite the whole thing under a different methodology."?
PuuliTuku
Sorry Noodle I didnt have the time yet to read the files carefully but wouldnt Ferring be the one to collect the revenues from those countries as theyre outside US?
PuuliTuku
Im a happy shareholder as long as they put these millions to good use and get that US approval.
PuuliTuku
If ye folks dont mind holding to the shares for the rest of the year I think ye have a decent shot at breaking even, dozen country launches plus US approval shouldcouldwould push this north of 3,5$ presplit, huh?
PuuliTuku